Correction to Selective Class I Phosphoinositide 3-Kinase Inhibitors: Optimization of a Series of Pyridyltriazines Leading to the Identification of a Clinical Candidate, AMG 511
Year: 2012
Type: erratum
Source: Journal of Medicinal Chemistry
DOI: 10.1021/jm301439j
Authors: Mark H. Norman, Kristin L. Andrews, Yunxin Y. Bo, Shon K. Booker, Sean Caenepeel, Victor J. Cee, Noel D. D’Angelo, Daniel J. Freeman, Bradley J. Herberich, Fang-Tsao Hong, Claire L. M. Jackson, Jian Jiang, Brian A. Lanman, Longbin Liu, John D. McCarter, Erin L. Mullady, Nobuko Nishimura, Liping H. Pettus, Anthony B. Reed, Tisha San Miguel, Adrian L. Smith, Markian M. Stec, Seifu Tadesse, Andrew Tasker, Divesh Aidasani, Xiaochun Zhu, Raju Subramanian, Nuria A. Tamayo, Ling Wang, Douglas A. Whittington, Bin Wu, Tian Wu, Ryan P. Wurz, Kevin Yang, Leeanne Zalameda, Nancy Zhang, Paul E. Hughes
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4254161334
